19 March 2010

Macfarlane

NO RECOMMENDATION

23/08/2000

Packaging company Macfarlane seems to be turning its back on recent tough times. At the interim stage to June, Macfarlane witnessed its pre-tax profits rise a healthy 10.4% to £6.7m. The group has been keeping its head down and nurturing its recent acquisitions, such as Marpak in Leeds, Monospec in Wrexham and Reseal-IT in Sweden. Restructuring and rebranding has put the packaging, plastics, merchanting and labels branches back on track, and this steady and solid approach is now paying off. The cash flow generated in the first half of the year was £1.3m, in comparison to the loss of £0.9m for the same time last year. Chairman John Ward remarked that he was pleased with the performance and was as determined as ever to 'drive the business forward'.

Sector: General Industrials

Companies: Macfarlane Group

Market cap: £81.8m

PE Forecast: 7.53

Share price: 64.5p

Subscribe today

£7,277

That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.

Subscribe now and receive a 50% discount

AIM in Review 2010

Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.

M&A on AIM 2009 - Which are the most active sectors for M&A? Which are the most active brokers to follow?

M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.

Free – Latest Stock Recommendations

Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.

Select your level of risk and we select the funds

Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.

The AIM Guide 2009/10

The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies.   Order your copy today and benefit from a £10 discount!

VCT Special Report 2009

This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.

Cash Shells Special Report 2009

Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

Popular Recommendations

Latest Recommendations

KBC Advanced Technologies 19/03/2010

Energy industry consultant KBC performed resiliently in recession-hit 2009 and entered 2010 with a robust order book.

TEG Group 19/03/2010

Organic composting specialist TEG is pursuing long-term contracts after turning £1.6m of annual losses into £155,000 pre-tax profits in calendar 2009.

European Goldfields 18/03/2010

European Goldfields hopes to move from AIM to the Full List by the end of 2010 after securing a key permit in Romania.

More Recommendations

Sectors

Vitesse Media Events